In order to verify the abnormal expression of LIN28B in EC patients, we used the TCGA database (https://portal.gdc.cancer.gov/), and found that its expression in patients with endometrial cancer (n = 552) was significantly higher than that in the control group (n = 35) (Fig. 1A). This evidence concerns the gene LIN28B and endometrial cancer.